About OrthoSon

OrthoSon develops an injectable bio-structural gel that restores degenerated intervertebral discs through a micro-invasive procedure. The patented polymer mimics natural disc tissue with 82% water content, gelling in situ to restore disc height and mechanical function. This addresses both pain and root causes of degenerative disc disease without spinal fusion or implants. The treatment targets 619 million people worldwide with low back pain, the leading cause of disability. As an FDA Breakthrough Device, the gel suppresses inflammatory markers while restoring a healthy disc environment. The procedure takes under 30 minutes with short recovery, offering earlier intervention for patients currently limited to pain management or surgery.